Knema

Knema

Manufacturer:

Pacific Pharma (Korea)

Distributor:

AA Medical
Concise Prescribing Info
Contents
Biphenyl-dimethyl-dicarboxylate
Indications/Uses
Treatment of chronic persisting & active hepatitis B, liver cirrhosis & drug-induced hepatitis associated w/ high SGPT level.
Dosage/Direction for Use
Adult 1 tab tds. May be increased to 2 tab tds after 1-2 mth if necessary. Treatment duration: 6 mth-1 yr.
Special Precautions
Chronic active hepatitis/cirrhosis.
Adverse Reactions
MIMS Class
Cholagogues, Cholelitholytics & Hepatic Protectors
ATC Classification
A05BA - Liver therapy ; Used in liver therapy.
Presentation/Packing
Form
Knema tab 25 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in